Bad Science vs. Good Leadership in Biotech ft. Sonal Kothari-Gupta, MD, PhD
Cultural Fit vs. Technical Skills: Hiring Strategies for Biotech Startups with Sonal Gupta
In this episode, Charles interviews Sonal Gupta, the SVP, Head of Clinical Development of AffyImmune Therapeutics-a biopharmaceutical firm focusing on affinity-tuned CAR T cell therapy for solid tumors.
They discuss about how far does a company get with bad science if they have great leaders, the effective leadership strategies in clinical development, and the importance of Cultural Fit in Hiring.
She also shares her passion for women in life sciences and her local group aimed at supporting women in the field.
Here's what you're in for:
01:30 Sonal's Background and Career Journey
03:21 Introduction to AffyImmune
04:41 Bad Science vs. Bad Leadership
06:52 Clinical Development Leadership
07:58 Making Difficult Decisions in Leadership
20:43 Leadership Journey and Interviewing Experience
21:53 Importance of Cultural Fit in Hiring
27:55 Advice for Junior Leaders
28:53 Passion and Enthusiasm in Interviews
34:57 Quick Fire Questions on Interviewing
36:41 Personal Journey into Medicine
37:38 Women in Leadership and Life Sciences
40:17 Conclusion and Final Thoughts
About Sonal Gupta
Sonal Gupta has over 15 years of industry experience, with leadership positions at AVROBIO, CRISPR Therapeutics, and Rubius Therapeutics.
She's led teams in translational research and medicine across areas like oncology and rare diseases. Her expertise spans clinical trial design, medical monitoring, and clinical data management, including biomarker strategies.
She holds a PhD in cancer research from the University of Bradford, UK, and a medical degree from Government Medical College, Surat, India.
Connect with Sonal Gupta:
Website:https://affyimmune.com/
LinkedIn:https://www.linkedin.com/in/sonalkotharigupta/
About Charles
Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.
He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.
In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.
Connect with Charles:
LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/
Website: https://www.discera-search.com/
